China SXT Pharmaceuticals SXTC Balance Sheet (2017-2026)

NASDAQ SXTC
$2.81 +0.29 (+11.51%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

China SXT Pharmaceuticals Quarterly Balance Sheet

Periods 19 quarters
Latest Mar 2026

China SXT Pharmaceuticals reported total assets of $34.75M and total liabilities of $5.05M for the quarter ended Mar 2026, up 50.3% year over year. This balance sheet covers 19 quarters of results from Dec 2017 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2017 Mar2018 Sep2018 Dec2018 Mar2019 Sep2019 Mar2020 Sep2020 Mar2021 Sep2021 Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.01M0.66M0.38M0.66M9.29M9.29M7.29M10.35M13.36M0.03M13.36M15.57M17.37M17.37M12.08M18.51M18.10M21.17M28.18M
Cash & Current Investments 0.01M0.66M0.38M0.66M9.29M9.29M7.29M10.35M13.36M0.03M13.36M15.57M17.37M17.37M12.08M18.51M18.10M21.17M28.18M
Receivables - NetNet Receivables 2.60M3.89M4.18M4.57M3.82M5.58M4.51M4.16M3.33M4.00M1.34M1.31M1.31M1.66M1.30M1.34M0.93M
Receivables - OtherOther Receivables 0.57M0.94M0.94M0.13M3.50M-3.59M0.46M1.27M2.98M0.29M2.75M0.23M0.08M1.10M0.42M1.36M2.07M
Receivables 3.54M3.89M4.31M8.07M0.23M6.04M5.77M7.14M3.62M6.75M1.58M1.31M1.40M2.77M1.72M2.70M3.00M
Raw Materials 0.35M0.34M0.60M0.19M0.24M0.32M0.35M0.44M0.30M0.28M
Finished Goods 0.62M0.62M0.58M0.59M0.45M0.55M0.60M0.45M0.51M0.64M
Inventory 1.27M1.07M1.01M0.85M0.89M0.87M0.86M0.84M1.02M0.63M0.53M0.49M0.79M0.87M0.83M0.75M0.78M
Current Deferred Tax AssetsCurrent Deferred Tax 0.05M
Prepaid Assets 0.91M0.73M707.34M2.02M4.62M2,174.23M1.86M1,816.64M0.86M1,040.04M0.23M137.98M0.03M0.22M0.32M0.31M0.37M
Current Assets 6.10M6.55M15.59M17.54M19.64M22.06M23.23M11.66M22.45M12.36M19.52M13.50M14.23M21.99M21.30M26.04M34.51M
Non-Current Assets
Construction in Progress 0.63M0.57M0.65M0.18M0.33M0.45M0.36M0.36M0.36M0.34M0.35M
Property, Plant & Equipment (Net)PP&E (Net) 0.86M0.78M1.16M1.76M1.57M1.46M1.43M1.30M1.23M1.01M0.96M0.81M0.33M0.23M0.18M0.15M0.12M
Long-Term Investments 3.50M
Intangibles 0.06M0.05M0.06M0.05M0.05M0.05M0.05M0.04M0.04M0.03M0.03M0.02M0.02M0.02M0.01M0.01M0.01M
Goodwill & Intangibles 0.06M0.05M0.06M0.05M0.05M0.05M0.05M0.04M0.04M0.03M0.03M0.02M0.02M0.02M0.01M0.01M0.01M
Long-Term Deferred Tax 0.01M0.01M0.01M0.11M0.02M0.32M0.04M0.03M
Other Non-Current Assets 0.10M0.18M0.16M-3.61M0.51M2.86M-8.85M9.31M9.46M8.43M8.74M8.31M8.55M0.03M0.03M368.00
Non-Current Assets 1.56M1.45M1.88M5.50M2.07M1.98M11.31M11.01M11.09M9.82M10.03M1.09M8.89M9.01M0.37M0.31M0.24M
Assets 7.66M7.95M17.47M23.05M21.70M24.04M34.55M22.67M33.55M22.18M29.55M14.59M23.13M31.00M21.66M26.35M34.75M
Liabilities
Current Liabilities
Accounts Payables 2.41M2.00M1.69M1.96M1.94M1.36M3.05M1.49M1.48M1.56M1.38M1.32M1.28M1.66M1.16M0.53M0.50M
Notes Payables 0.39M0.19M0.23M0.06M0.04M0.05M0.04M0.02M2.03M0.17M0.27M0.49M0.70M0.70M0.98M0.36M
Payables 2.79M2.19M1.92M2.02M1.99M1.40M3.08M1.52M3.52M1.56M1.55M1.58M1.77M2.36M1.86M1.51M0.85M
Accumulated Expenses 0.42M0.31M0.69M0.70M0.13M3.05M3.36M3.53M3.28M3.14M3.25M2.77M2.92M2.94M3.27M3.30M
Other Accumulated Expenses 0.15M0.21M2.48M0.17M0.29M0.73M0.82M2.12M8.70M1.03M0.42M1.05M7.45M0.67M0.92M0.88M
Short term Debt 0.03M4.94M6.64M0.01M1.21M0.01M0.02M0.02M0.01M0.01M0.00M
Current Leases 1.53M8.31M0.06M0.06M
Current Taxes 0.87M1.16M1.06M1.03M0.99M1.32M1.16M1.18M1.17M1.07M1.10M1.04M1.05M1.09M1.03M1.04M0.00M
Current Deferred Revenue 0.29M0.12M0.06M0.12M0.30M0.22M0.26M0.22M0.08M0.07M0.17M0.19M0.19M0.19M0.06M0.07M0.10M
Total Current Liabilities 4.37M3.99M6.32M10.76M12.26M5.51M18.58M8.88M17.12M7.29M14.50M9.20M8.90M15.66M6.01M5.96M4.35M
Non-Current Liabilities
Non-Current Debt 0.04M0.06M0.04M0.02M0.01M0.12M0.11M0.12M0.12M0.10M0.07M0.64M
Convertible Debt 0.82M
Preferred Stock Liabilities 0.29M55.38M
Operating Leases 0.25M0.20M0.18M0.18M0.12M0.09M0.05M
Other Non-Current Liabilities 0.08M0.07M0.11M0.10M0.47M0.48M0.12M0.11M0.11M0.15M0.21M0.22M0.05M0.02M0.02M
Total Non-Current Liabilities 0.04M0.87M0.04M0.02M0.01M8.40M17.34M7.52M0.37M0.31M0.29M0.30M0.21M0.16M0.70M
Total Liabilities 4.37M3.35M6.36M11.64M12.30M5.52M18.59M8.88M17.46M7.63M14.86M9.51M9.20M15.96M6.22M6.12M5.05M
Shareholder's Equity
Total Debt 0.39M0.19M0.30M5.05M6.72M0.06M0.04M0.02M2.05M1.21M0.29M0.39M0.63M0.83M0.81M1.05M1.00M
Common Equity 3.29M4.60M11.11M11.41M9.40M18.52M15.96M13.79M16.08M14.55M14.69M5.08M13.93M15.03M15.44M20.23M29.71M
Liabilities and Shareholders Equity 7.66M7.95M17.47M23.05M21.70M24.04M34.55M22.67M33.55M22.18M29.55M14.59M23.13M31.00M21.66M26.35M34.75M
Retained Earnings 1.54M2.54M3.08M0.74M-7.20M-5.82M-9.95M-13.04M-15.69M-17.18M-21.61M-31.31M-24.71M-25.51M-28.02M-34.38M-34.22M
Preferred Shares 0.02M0.02M0.02M1.45M4.35M44.53M

China SXT Pharmaceuticals Balance Sheet API

Pull China SXT Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SXTC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY